Cutaneous side-effects of kinase inhibitors and blocking antibodies (Q36181698)

12 August 2017

1 reference

title

Cutaneous side-effects of kinase inhibitors and blocking antibodies (English)

1 reference

12 August 2017

1 reference

4

Axel Le Cesne

0 references

Caroline Robert

1

object named as

Caroline Robert

0 references

Jean-Charles Soria

2

object named as

Jean-Charles Soria

0 references

Bernard Escudier

9

object named as

Bernard Escudier

1 reference

12 August 2017

12

Thierry Le Chevalier

1 reference

12 August 2017

Alain Spatz

3

1 reference

12 August 2017

David Malka

5

1 reference

12 August 2017

Patricia Pautier

6

1 reference

12 August 2017

Janine Wechsler

7

1 reference

12 August 2017

Catherine Lhomme

8

1 reference

12 August 2017

Valérie Boige

10

1 reference

12 August 2017

Jean-Pierre Armand

11

1 reference

12 August 2017

publication date

1 July 2005

1 reference

Lancet Oncology Commission

12 August 2017

published in

1 reference

12 August 2017

volume

6

1 reference

12 August 2017

issue

7

1 reference

12 August 2017

page(s)

491-500

1 reference

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Tyrosine kinase inhibition and grey hair

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Gefitinib--a novel targeted approach to treating cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Epidermal growth factor as a biologic switch in hair growth cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Inflammatory skin diseases, T cells, and immune surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Determinants of tumor response and survival with erlotinib in patients with non--small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Skin rash and good performance status predict improved survival with gefitinib in patients with advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Chromatin structure of the EGFR gene suggests a role for intron 1 sequences in its regulation in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Practical management of patients with non-small-cell lung cancer treated with gefitinib

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Doxycycline is anti-inflammatory and inhibits staphylococcal exotoxin-induced cytokines and chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Epidermal growth factor receptor inhibition induces trichomegaly.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Strain-dependent epithelial defects in mice lacking the EGF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

The microscopic appearance of waved-2 mouse hairs

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Eyelash length in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Expression of human immunodeficiency virus type 1 gag modulates ligand-induced downregulation of EGF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Proteomic identification of 14-3-3 sigma as a common component of the androgen receptor and the epidermal growth factor receptor signaling pathways of the human prostate epithelial cell line M12.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Paronychia induced by cetuximab, an antiepidermal growth factor receptor antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Etretinate and the nails (study of 130 cases) possible mechanisms of some side-effects

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Paronychia and pyogenic granuloma of the great toes in patients treated with indinavir

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Phase I evaluation of all-trans-retinoic acid in adults with solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Cutaneous manifestations of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Retinoids suppress epidermal growth factor-associated cell proliferation by inhibiting epidermal growth factor receptor-dependent ERK1/2 activation.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Indications for imatinib mesylate therapy and clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Kinase inhibition with BAY 43-9006 in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Antineoplastic therapy-induced palmar plantar erythrodysesthesia ('hand-foot') syndrome. Incidence, recognition and management

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Splinter haemorrhages

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Subungueal-Splinter Hemorrhage an Early Sign of Thromboangitis Obliterans

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

The prevalence of splinter haemorrhages

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

1 reference

7 January 2021

Hair depigmentation is a biological readout for pharmacological inhibition of KIT in mice and humans

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

SCF/c-kit signaling is required for cyclic regeneration of the hair pigmentation unit

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Fas and c-kit are Involved in the Control of Hair Follicle Melanocyte Apoptosis and Migration in Chemotherapy-Induced Hair Loss

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Imatinib mesylate and gray hair

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Imatinib mesylate causes hypopigmentation in the skin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Imatinib treatment: specific issues related to safety, fertility, and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Unexpected pleural effusions in 3 pediatric patients treated with STI-571.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Cerebral oedema as a possible complication of treatment with imatinib

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Mechanisms of angiotensin II-induced platelet-derived growth factor gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Platelet-derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3' kinase signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

Ocular side-effects associated with imatinib mesylate (Gleevec).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970243-6

7 January 2021

10.1016/S1470-2045(05)70243-6

Identifiers

DOI

1 reference

12 August 2017

1 reference